🚀 VC round data is live in beta, check it out!
- Public Comps
- Qlife Holding
Qlife Holding Valuation Multiples
Discover revenue and EBITDA valuation multiples for Qlife Holding and similar public comparables like Neola Medical, ScandiDos, Inventionmed, Spineway and more.
Qlife Holding Overview
About Qlife Holding
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
Founded
2019
HQ

Employees
35
Website
Sectors
Financials (FY)
EV
$7M
Qlife Holding Financials
Qlife Holding reported last fiscal year revenue of $35K and negative EBITDA of ($2M).
In the same fiscal year, Qlife Holding generated ($73K) in gross profit, ($2M) in EBITDA losses, and had net loss of ($2M).
Qlife Holding P&L
In the most recent fiscal year, Qlife Holding reported revenue of $35K and EBITDA of ($2M).
Qlife Holding expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $35K | XXX | XXX | XXX |
| Gross Profit | — | XXX | ($73K) | XXX | XXX | XXX |
| Gross Margin | — | XXX | (207%) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (5591%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (5983%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (6345%) | XXX | XXX | XXX |
| Net Debt | — | — | $779K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Qlife Holding Stock Performance
Qlife Holding has current market cap of $6M, and enterprise value of $7M.
Market Cap Evolution
Qlife Holding's stock price is $0.21.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7M | $6M | 0.3% | XXX | XXX | XXX | $-0.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialQlife Holding Valuation Multiples
Qlife Holding trades at 193.8x EV/Revenue multiple, and (3.5x) EV/EBITDA.
Qlife Holding Financial Valuation Multiples
As of April 20, 2026, Qlife Holding has market cap of $6M and EV of $7M.
Equity research analysts estimate Qlife Holding's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Qlife Holding has a P/E ratio of (2.7x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6M | XXX | $6M | XXX | XXX | XXX |
| EV (current) | $7M | XXX | $7M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 193.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (3.5x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (3.2x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (93.7x) | XXX | XXX | XXX |
| P/E | — | XXX | (2.7x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (3.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Qlife Holding Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Qlife Holding Margins & Growth Rates
Qlife Holding's revenue in the last fiscal year grew by 548%.
Qlife Holding's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.1M for the same period.
Qlife Holding Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 548% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (5591%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (51%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 5776% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Qlife Holding Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Qlife Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Neola Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| ScandiDos | XXX | XXX | XXX | XXX | XXX | XXX |
| Inventionmed | XXX | XXX | XXX | XXX | XXX | XXX |
| Spineway | XXX | XXX | XXX | XXX | XXX | XXX |
| Bio-Gate | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Qlife Holding M&A Activity
Qlife Holding acquired XXX companies to date.
Last acquisition by Qlife Holding was on XXXXXXXX, XXXXX. Qlife Holding acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Qlife Holding
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialQlife Holding Investment Activity
Qlife Holding invested in XXX companies to date.
Qlife Holding made its latest investment on XXXXXXXX, XXXXX. Qlife Holding invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Qlife Holding
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Qlife Holding
| When was Qlife Holding founded? | Qlife Holding was founded in 2019. |
| Where is Qlife Holding headquartered? | Qlife Holding is headquartered in Sweden. |
| How many employees does Qlife Holding have? | As of today, Qlife Holding has over 35 employees. |
| Is Qlife Holding publicly listed? | Yes, Qlife Holding is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Qlife Holding? | Qlife Holding trades under QLIFE ticker. |
| When did Qlife Holding go public? | Qlife Holding went public in 2020. |
| Who are competitors of Qlife Holding? | Qlife Holding main competitors are Neola Medical, ScandiDos, Inventionmed, Spineway. |
| What is the current market cap of Qlife Holding? | Qlife Holding's current market cap is $6M. |
| What is the current revenue of Qlife Holding? | Qlife Holding's last fiscal year revenue is $35K. |
| What is the current EV/Revenue multiple of Qlife Holding? | Current revenue multiple of Qlife Holding is 193.8x. |
| Is Qlife Holding profitable? | No, Qlife Holding is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.